Synopsis
Synopsis
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Cornutamine
2. Ergo Kranit
3. Ergo Sanol
4. Ergo-kranit
5. Ergodryl Mono
6. Ergomar
7. Ergostat
8. Ergotamine
9. Ergotamine Tartrate
10. Ergotamine Tartrate (2:1)
11. Ergotaminine
12. Gynergen
13. Lingraine
14. Mono, Ergodryl
15. Tartrate, Ergotamine
1. Ergotamine Tartrate
2. Ergotamine Bitartrate
3. 379-79-3
4. Schembl8045
5. Akos015897172
6. Ac-14836
Molecular Weight | 731.7 g/mol |
---|---|
Molecular Formula | C37H41N5O11 |
Hydrogen Bond Donor Count | 7 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 7 |
Exact Mass | 731.28025714 g/mol |
Monoisotopic Mass | 731.28025714 g/mol |
Topological Polar Surface Area | 233 Ų |
Heavy Atom Count | 53 |
Formal Charge | 0 |
Complexity | 1350 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Ergomar |
PubMed Health | Ergotamine Tartrate (By mouth) |
Drug Classes | Antimigraine |
Active Ingredient | Ergotamine tartrate |
Dosage Form | Tablet |
Route | Sublingual |
Strength | 2mg |
Market Status | Prescription |
Company | Rosedale Therapeutic |
2 of 2 | |
---|---|
Drug Name | Ergomar |
PubMed Health | Ergotamine Tartrate (By mouth) |
Drug Classes | Antimigraine |
Active Ingredient | Ergotamine tartrate |
Dosage Form | Tablet |
Route | Sublingual |
Strength | 2mg |
Market Status | Prescription |
Company | Rosedale Therapeutic |
Adrenergic alpha-1 Receptor Agonists
Compounds that bind to and activate ADRENERGIC ALPHA-1 RECEPTORS. (See all compounds classified as Adrenergic alpha-1 Receptor Agonists.)
Analgesics, Non-Narcotic
A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. (See all compounds classified as Analgesics, Non-Narcotic.)
Oxytocics
Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (ABORTIFACIENTS). Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. (From AMA Drug Evaluations, 1994, p1157) (See all compounds classified as Oxytocics.)
Serotonin Receptor Agonists
Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)
Vasoconstrictor Agents
Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)
GDUFA
DMF Review : Reviewed
Rev. Date : 2012-11-23
Pay. Date : 2012-11-08
DMF Number : 24782
Submission : 2011-03-23
Status : Active
Type : II
Certificate Number : R1-CEP 2007-328 - Rev 03
Issue Date : 2020-02-06
Type : Chemical
Substance Number : 224
Status : Valid
Registration Number : 220MF10122
Registrant's Address : Ostravska 305/29, Komarov, 747 70 Opava, Czech Republic
Initial Date of Registration : 2008-04-28
Latest Date of Registration : --
Available Reg Filing : ASMF |
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-01-16
Pay. Date : 2013-12-02
DMF Number : 22932
Submission : 2009-07-06
Status : Active
Type : II
Certificate Number : R1-CEP 2008-291 - Rev 04
Issue Date : 2021-08-05
Type : Chemical
Substance Number : 224
Status : Valid
NDC Package Code : 55486-1581
Start Marketing Date : 2012-06-03
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5765
Submission : 1985-03-27
Status : Inactive
Type : II
Certificate Number : R0-CEP 2001-255 - Rev 01
Issue Date : 2004-10-13
Type : Chemical
Substance Number : 224
Status : Withdrawn by Holder
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3038
Submission : 1977-10-12
Status : Inactive
Type : II
NDC Package Code : 47848-001
Start Marketing Date : 2022-01-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3358
Submission : 1978-10-13
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3210
Submission : 1978-04-11
Status : Inactive
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?